APLS logo
APLS

Apellis Pharmaceuticals Inc

Biotechnology

Apellis Pharmaceuticals Inc (APLS) Earnings

Last reported
April 30, 2026
EPS estimate
-$0.36
EPS actual
Revenue est.
$208.3M
Revenue actual